This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Myriad Genetics Inc (MYGN)

NASDAQ: Services

Company Cash Flow
Jun 2013 Jun 2012 Jun 2011 Jun 2010
Cash Flow From Operating Activities
Net Income (Loss) 147.14M 112.15M 100.71M 152.30M
Operating Gains/Losses -157.00K -372.00K -3.00K 99.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -67.89M -37.26M -15.19M -21.66M
(Increase) Decrease in Inventories 6.57M -3.43M 203.00K 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 53.16M 0.00
(Decrease) Increase In Payables 7.99M -1.25M 287.00K -5.31M
(Decrease) Increase In Other Current Liabilities 11.56M 11.22M 924.00K -393.00K
(Increase) Decrease In Other Working Capital 746.00K 748.00K -425.00K 22.00K
Other Non-Cash Items 51.55M 16.13M -15.71M 51.05M
Net Cash From Continuing Operations 173.87M 141.85M 130.76M 155.09M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 173.87M 141.85M 130.76M 155.09M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 52.16M
Purchases of Property, Plant & Equipment -11.37M -10.26M -5.79M -7.90M
Acquisitions -5.00M -8.80M -79.42M 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 -477.56M
Other Cash from Investing Activities 0.00 -17.00M -100.00K 356.62M
Cash Provided by Financing Activities
Net Cash From Investing Activities -75.59M -38.89M -54.39M -76.67M
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 57.82M 25.03M 25.06M 22.30M
Repayment of Long-Term Debt 0.00 0.00 0.00 0.00
Repurchase of Capital Stock -146.27M -128.47M -200.49M -71.39M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 7.89M 34.19M 58.83M 0.00
Net Cash From Financing Activities -80.56M -69.24M -116.60M -49.09M
Effect of Exchange Rate Changes 0.00 -42.00K 71.00K 0.00
Net Change in Cash & Cash Equivalents 17.72M 33.67M -40.16M 29.33M
MYGN News

MYGN Myriad Genetics Inc

Analysts Ratings for MYGN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 8 8 9 9
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2
GET MYGN ANALYST REPORT

Brokerage Partners

MYGN Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs